PRN Pharmacal

What PRN Pharmacal does

PRN Pharmacal, founded in 1978 and headquartered in Pensacola, Florida, is a veterinary pharmaceutical and nutritional products company that develops, manufactures, and distributes prescription and over-the-counter products for companion animals (dogs, cats, horses) and livestock (cattle, sheep, goats, pigs). The company's portfolio spans FDA-approved and conditionally-approved pharmaceuticals (Felycin-CA1, KBroVet, PROIN, PROIN ER, Reconcile, Liavium-CA1, ReBalance, Firocoxib), nutritional therapeutics (the Duralactin line, CitraVet, CranMate, Endosorb, GastroMate, ProZyme), nutritional supplements for livestock (Calsorb, CMPK Drench Plus, Hi-Energy, Magna Gel, Liqui-Tinic, STAT), EPA-registered parasite control products (Vet-Kem and Mycodex brands), and surgical/wound-care devices (Monomend, Polymend, NY-STA, PRO-STA sutures, ReGum Vet, Hexa-Caine).

The business operates on a prescription-channel distribution model: pharmaceutical products are dispensed exclusively through licensed veterinarians in compliance with federal law, with additional reach via an authorized sellers network. The company employs a sales-led go-to-market motion that combines Lunch & Learn educational visits to veterinary clinics with conference presence at VMX and WVC, supplemented by product-dedicated microsites and LinkedIn engagement. Revenue is generated through one-time product sales across the pharmaceutical, nutritional therapeutic, nutritional supplement, parasite control, and surgical categories.

PRN Pharmacal operates as a subsidiary of PBI-Gordon Companies following the May 2025 acquisition of TriviumVet, which added Felycin-CA1 — the first FDA-conditionally approved drug for feline hypertrophic cardiomyopathy — and cardiovascular R&D capability to the portfolio. The company holds 8 FDA NADA/ANADA pharmaceutical approvals and 5 EPA registrations, with multiple "first-in-class" regulatory positions that anchor its competitive positioning.

Name

PRN Pharmacal

Legal name

PRN Pharmacal

Website

https://prnpharmacal.com

Company type

Private

Founded year

1978

Operating status

Operating

Headcount range

101–250 employees

Short description

PRN Pharmacal is a Pensacola-based veterinary pharmaceutical and nutritional products company, founded in 1978, that develops and distributes FDA-approved drugs, nutritional therapeutics, parasite control products, and surgical supplies through licensed veterinarians for companion animals and livestock in the United States.

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceuticals

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Veterinary Services (54194)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Surgical & Medical Instruments & Apparatus (3841), Agricultural Prod-Livestock & Animal Specialties (200)

akta.pro primary industry

Veterinary Pharmacy, Vaccine & Biologics Services (AFAEANAK)

akta.pro secondary industries

Pain Management, Anesthesia & Critical Care Drugs (HLAMAEAF), Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB), Veterinary Pharmaceutical Wholesalers & Distributors (HLAMAIAA)

Keywords

• Veterinary pharmaceuticals
• Animal health products
• Nutritional supplements
• Parasite control products
• Wound care products

Headquarters

HQ city

Pensacola

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Products: Sale of FDA-approved and conditionally-approved veterinary pharmaceuticals for companion animals (dogs, cats, horses) and livestock. Products are prescription-only, distributed through licensed veterinarians.
2. Nutritional Therapeutics: Sale of nutritional supplements and therapeutic products for pets and livestock, including joint health supplements, digestive aids, and specialty formulations.
3. Parasite Control Products: EPA-registered environmental flea and tick control products including sprays, foggers, and yard treatments.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

PRN Pharmacal develops, manufactures, and markets FDA-approved and conditionally-approved veterinary pharmaceuticals, nutritional therapeutics, nutritional supplements, parasite control products, and surgical/wound care products for companion animals (dogs, cats, horses) and livestock (cattle, sheep, goats, pigs). Products are sold exclusively through licensed veterinarians and authorized sellers, with federal law restricting prescription drugs to use by or on the order of a licensed veterinarian.

Product overview

PRN Pharmacal is a veterinary pharmaceutical and nutritional supplement company offering a broad portfolio of products across multiple categories. The portfolio includes 9 FDA-approved pharmaceuticals (Felycin®-CA1, Firocoxib products, KBroVet®, Liavium™-CA1, PROIN ER™, PROIN®, ReBalance®, and Reconcile®) for companion animals (dogs, cats) and horses addressing conditions including cardiomyopathy, epilepsy, osteoarthritis, anxiety, and urinary incontinence. The Nutritional Therapeutics line features the Duralactin® brand (with Microlactin®) for joint health and inflammation management across dogs, cats, and horses, plus supplements for urinary health (CitraVet®, CranMate®) and digestive support (Endosorb®, GastroMate®, ProZyme®). The Nutritional Supplements category serves livestock (cattle, horses, sheep, goats, pigs) with calcium, energy, and mineral supplements (CMPK products, Hi-Energy, Magna Gel, Liqui-Tinic, STAT). Parasite Control products include the Vet-Kem® and Mycodex® brands for flea, tick, and insect control in homes and yards. Surgical & Wound Care offerings include sutures (Monomend®, NY-STA®, Polymend®, PRO-STA®), Hexa-Caine™ anti-itch spray, and ReGum™ Vet for periodontitis. Drug Delivery devices include Pet Pillers and Safe-Flow Dispensers. The portfolio was expanded through the acquisition of TriviumVet, bringing Felycin®-CA1, the first FDA-conditionally approved drug for feline hypertrophic cardiomyopathy.

Differentiator

Problem solved

Functional benefit

Brands

• Felycin: Disease-modifying drug for feline hypertrophic cardiomyopathy (sirolimus delayed-release tablets)
• KBroVet
• PROIN
• Reconcile
• Firocoxib
• Duralactin
• ReBalance
• Liavium-CA1

Products and services

• Felycin-CA1 (sirolimus delayed-release tablets) Once-weekly delayed-release tablets indicated for the management of ventricular hypertrophy with subclinical hypertrophic cardiomyopathy (HCM) in cats; the first disease-modifying drug for feline HCM, conditionally approved by FDA (NADA 141-604). For licensed veterinarians.
• Firocoxib Chewable Tablets for Dogs Coxib-class non-steroidal anti-inflammatory drug (NSAID) administered for the control of pain and inflammation associated with osteoarthritis and postoperative pain associated with soft-tissue and orthopedic surgery in dogs. For licensed veterinarians.
• Firocoxib Tablets for Horses Non-steroidal anti-inflammatory drug (NSAID) administered once daily for up to 14 days for the control of pain and inflammation associated with osteoarthritis in horses. For licensed veterinarians.
• KBroVet (potassium bromide chewable tablets) French-vanilla flavored chewable tablets for the control of seizures associated with idiopathic epilepsy in dogs. The first FDA fully approved pharmaceutical for this indication. For licensed veterinarians.
• Liavium-CA1 (pregabalin chewable tablets) Conditionally FDA-approved chewable tablets for the management of pain and clinical signs associated with Chiari-like malformation and syringomyelia in dogs. Schedule V controlled substance. For licensed veterinarians.
• PROIN ER (phenylpropanolamine hydrochloride extended-release tablets) FDA-approved extended-release tablets indicated for the control of urinary incontinence due to urethral sphincter hypotonus in dogs. The only once-daily FDA-approved treatment for canine UI. For licensed veterinarians.
• PROIN (phenylpropanolamine hydrochloride chewable tablets) Chewable tablets for the control of urinary incontinence due to urethral sphincter hypotonus in dogs. For licensed veterinarians.
• ReBalance Antiprotozoal Oral Suspension Oral suspension containing sulfadiazine and pyrimethamine indicated for the treatment of horses with equine protozoal myeloencephalitis (EPM) caused by Sarcocystis neurona. For licensed veterinarians.
• Reconcile (fluoxetine hydrochloride chewable tablets) Chewable tablets indicated for the treatment of canine separation anxiety in conjunction with a behavior modification plan. For licensed veterinarians.
• CitraVet Liver-flavored chewable potassium citrate supplement for dogs and cats designed to support urine pH management by increasing urine alkalinity.
• CoproBan Roast beef flavored soft chew coprophagia deterrent for dogs, cats, and puppies, formulated with MSG and cellulose to render stool taste unpleasant.
• CranMate Pork-flavored chewable tablet containing American Cranberry extract rich in Type-A proanthocyanidins (PACs) and antioxidants to support urinary tract health in dogs and cats.
• Duralactin Canine Chewable Tablets Vanilla-flavored chewable tablets for long-term management of inflammatory conditions in dogs and puppies, containing Microlactin (dried milk protein concentrate from hyperimmunized cows).
• Duralactin Canine Joint Plus Soft Chews Chicken-liver flavored soft chews for maintaining healthy cartilage and joint function while managing inflammation in dogs and puppies, containing Microlactin, Glucosamine HCl, and MSM.
• Duralactin Canine Soft Chews Chicken-liver flavored soft chews for long-term management of inflammation in dogs and puppies, containing Microlactin (dried milk protein concentrate).
• Duralactin Equine Joint Plus Pellets Easy-to-feed pellets for maintaining healthy cartilage and joint function while managing inflammation in horses, containing Microlactin, Glucosamine HCl, Chondroitin, and Vitamin C.
• Duralactin Equine Pellets Pellets for the management of inflammatory conditions in horses, containing Microlactin (dried milk protein concentrate from hyperimmunized cows).
• Duralactin Feline + Fatty Acids Soft Chews Chicken-liver flavored soft chews for cats and kittens to help manage inflammation, containing Microlactin and Omega 3 and Omega 6 Fatty Acids.
• Duralactin Feline Capsules Gelatin capsules for cats and kittens to help manage inflammation, containing Microlactin (dried milk protein concentrate).
• Duralactin Feline L-Lysine Paste Natural chicken-flavor paste in a dial-dose syringe for cats and kittens to support respiratory and ocular health while managing inflammation, containing L-Lysine and Omega fatty acids.
• Calsorb Gel-based oral calcium supplement for dogs providing 170 mg/mL calcium in a gel base delivered via clear dosing syringe for maintaining healthy calcium levels when IV is not feasible.
• CMPK Drench Plus Liquid drench solution providing calcium, phosphorus, magnesium, and potassium for livestock needing additional electrolytes, with up to 75% calcium in free ionic form.
• CMPK Slow Release Bolus Slow release bolus providing calcium, magnesium, phosphates, potassium, Vitamin D3 and Vitamin E for livestock requiring nutritional supplementation.
• Hi-Energy Supplement High calorie oral gel supplement for livestock containing amino acids, B-complex vitamins, poultry liver, iron and propylene glycol to support animals with additional energy requirements due to growth, trauma or stress.
• High Potency Calcium Gel Quickly absorbed oral calcium gel supplement for cattle in easy-to-use tube for administration before and after calving or during times when livestock may need additional calcium.
• Liqui-Tinic 4X Liver-flavored liquid iron and B-complex vitamin supplement for livestock and companion animals to correct nutritional deficiencies and support overall health and well-being.
• Magna Gel Oral magnesium gel supplement for beef and dairy cattle to support animals suffering from conditions related to magnesium deficiency.
• OPTIMA 365 Essential fatty acids nutritional supplement providing optimally balanced Omega-3, Omega-6 and Omega-9 fatty acids with vitamins and minerals to support overall pet health, healthy skin and coat, and reduction of non-seasonal shedding in dogs and cats.
• STAT Concentrated high-calorie vanilla-flavored liquid supplement at 185 calories per ounce to help restore hydration and nutrient levels in convalescing, underweight, lactating and working animals.
• Endosorb Bolus Anti-diarrheal bolus containing activated attapulgite with roasted powdered carob pulp, citrus pectin and magnesium trisilicate to aid in the supportive treatment of intestinal disturbances in horses, cattle and other ruminants.
• Endosorb Suspension Flavored and sweetened aqueous anti-diarrheal suspension containing activated attapulgite for oral use in animals to support stool consistency by stabilizing stool viscosity and soothing the gastrointestinal tract.
• Endosorb Tablets Anti-diarrheal tablets for dogs and cats containing activated attapulgite with roasted powdered carob pulp, citrus pectin and magnesium trisilicate for supportive treatment of intestinal disturbances.
• GastroMate Live direct-fed microbial gel containing billions of live microorganisms, pasteurized spray dried egg product, vitamins, and antioxidants to support intestinal health and gastrointestinal tract function in puppies and dogs.
• Pet-Ema Disposable single-use enema for dogs and cats containing Dioctyl Sodium Sulfosuccinate with glycerin and sorbic acid as a stool softener and lubricant for maintaining healthy lower bowel function.
• ProZyme Plant-derived enzyme powder supplement supporting breakdown of food and reinforcing animal's own digestive system, containing alpha-amylase, lipase, cellulase, and protease from natural origins.
• Mycodex Plus Environmental Control Spray Aerosol household spray with botanically derived insecticide Linalool that kills all four stages of fleas (adults, eggs, pupae, larvae) and controls re-infestation for up to 210 days, also kills ticks, roaches, ants, and other insects.
• Vet-Kem Carpet and Premise Spray EPA-registered home aerosol spray delivering 100% knock down of adult fleas in ten minutes and preventing re-infestation for up to 7 months, treating up to 2,000 square feet.
• Vet-Kem Fogger Home fogger containing three 3-oz. cans that kills fleas and hatching eggs, ticks, cockroaches, ants, spiders, mosquitoes and silverfish, preventing flea re-infestation for up to seven months.
• Vet-Kem Home Spray Home pump spray that kills fleas, ticks, cockroaches, ants, spiders, flies, mosquitoes, bed bugs and other listed insects, preventing new infestations for up to seven months.
• Vet-Kem Yard Spray Home yard spray with 2.5% permethrin that attaches to garden hose to treat up to 5,000 square feet and kills mosquitoes, fleas, ticks, ants and over 40 other insects including deer ticks that may cause Lyme disease.
• Hexa-Caine Anti-Itch Spray Topical anti-itch spray for dogs, cats and horses containing Lidocaine 2.46%, Benzethonium Chloride, lanolin, aloe vera and bitter flavoring agent to deter wound licking.
• Monomend MaX Absorbable Sutures Monofilament long-term absorbable suture for veterinary surgical applications.
• Monomend MT Absorbable Sutures Monofilament mid-term absorbable suture for veterinary surgical applications.
• Monomend ST Absorbable Sutures Monofilament short-term absorbable suture for veterinary surgical applications.
• NY-STA Non-Absorbable Sutures Monofilament non-absorbable suture for veterinary surgical applications.
• Polydrape Surgical Drape Surgical drape for veterinary surgical applications.
• Polymend MT Absorbable Sutures Braided mid-term absorbable suture for veterinary surgical applications.
• PRO-STA FLX Non-Absorbable Sutures Monofilament non-absorbable suture for veterinary surgical applications.
• ReGum Vet Innovative scaffold for advanced periodontitis in dogs.
• Pet Pillers Device for administering oral medications to pets.
• Safe-Flow Dispensers Oral gel dispenser devices for administering nutritional supplements to livestock.

Quantifiable outcome

• Felycin-CA1 is the first disease-modifying drug for cats with subclinical HCM
• +1 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• PBI-Gordon CompaniesflagshipStrategic or Co-development Partner · 5 May 2025PBI-Gordon Companies acquired TriviumVet on May 5, 2025, a veterinary research and development firm. The acquisition expanded PBI-Gordon/PRN Pharmacal's portfolio with Felycin-CA1, the first FDA-conditionally approved drug for feline hypertrophic cardiomyopathy. TriviumVet brought expertise in veterinary R&D, particularly in cardiovascular treatments for cats.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Elanco Animal Health: Major global animal health company with a deep pharmaceutical and therapeutic portfolio for companion animals and livestock. Competes directly with PRN in pain management, parasiticides, and chronic-disease therapeutics for dogs and cats, and operates a comparable veterinary-channel go-to-market.
• Ceva Santé Animale: Global veterinary pharmaceutical company with companion-animal, livestock, and poultry product lines, including cardiology, pain management, and behavioral health — overlapping PRN's therapeutic areas across both dogs/cats and production animals.
• Zoetis: The largest global animal health company, offering pharmaceuticals, vaccines, diagnostics, and parasite control across companion and livestock animals. Direct portfolio overlap with PRN Pharmacal across pain/inflammation (NSAIDs), cardiology, parasiticide, and nutritional/therapeutic categories, though at vastly greater scale and broader indication coverage.

Direct peers

• Bimeda: Privately held global veterinary pharmaceutical and nutrition company offering pharmaceuticals, nutritional supplements, and parasiticides for livestock and companion animals — closely aligned with PRN's portfolio breadth and dual-species focus.
• Dechra Pharmaceuticals: Specialty veterinary pharmaceuticals company (acquired by EQT) focused on companion-animal endocrinology, dermatology, ophthalmology, and pain management — closely aligned with PRN's specialty-pharma positioning and prescription-only veterinary distribution model.
• Phibro Animal Health: Animal health and nutrition company serving livestock and companion animals with pharmaceuticals, nutritional specialties, and parasiticides. Closely matches PRN's livestock/companion dual-market strategy and emphasis on nutritional supplements and antiprotozoal therapy.
• Virbac: Global animal health company focused on companion-animal and livestock pharmaceuticals, vaccines, and parasiticides, with significant overlap in dermatology, cardiology, and pain management products sold through the veterinary channel.
• Vetoquinol: Independent veterinary pharmaceutical company with companion-animal and livestock product lines, including pain/inflammation, cardiology, and nutraceuticals. Directly comparable specialty-pharma model with similar therapeutic categories and veterinary-channel distribution.

Others

• Covetrus (formerly MWI Animal Health / Henry Schein Animal Health): Veterinary distribution and technology platform supplying pharmaceuticals, supplies, and practice-management software to veterinary clinics. Functions as a downstream channel partner/competitor that carries many of the same therapeutic categories PRN manufactures and distributes.

Emerging players

• Heska (acquired by Mars Petcare): Specialty veterinary diagnostics and therapeutics company (now part of Mars Petcare) with point-of-care diagnostics, allergy treatment, and select pharmaceuticals. Comparable specialty-veterinary positioning and veterinary-channel distribution, though focused more on diagnostics and immunology than small-molecule pharmaceuticals.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/prn-pharmacal

Compliance14 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PRN Pharmacal